Pfizer Inc
Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%
Pfizer Top 3 U.S. Pharmaceutical Wholesalers by Year
Top 3 U.S. Pharmaceutical Wholesalers — Share of gross trade accounts receivable (%) (%)
Pfizer Top 3 U.S. Pharmaceutical Wholesalers: 40.0% in FY2025, up 6.0 pts from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-26) ↗
Share of Pfizer total revenues and year-end trade receivables concentrated in the three major U.S. wholesale distributors.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Top 3 U.S. Pharmaceutical Wholesalers — Share of gross trade accounts receivable (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 40.0% | +6.0 pts | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 34.0% | -8.0 pts | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 42.0% | +10.0 pts | Form 10-K (filed 2025-02-27) ↗ |
| FY2022 | Dec 31, 2022 | 32.0% | +8.0 pts | Form 10-K (filed 2024-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 24.0% | -6.0 pts | Form 10-K (filed 2023-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 30.0% | +5.0 pts | Form 10-K (filed 2023-02-23) ↗ |
| FY2019 | Dec 31, 2019 | 25.0% | -4.0 pts | Form 10-K (filed 2022-02-24) ↗ |
| FY2018 | Dec 31, 2018 | 29.0% | -7.0 pts | Form 10-K (filed 2021-02-25) ↗ |
| FY2017 | Dec 31, 2017 | 36.0% | +7.0 pts | Form 10-K (filed 2020-02-27) ↗ |
| FY2016 | Dec 31, 2016 | 29.0% | +6.0 pts | Form 10-K (filed 2019-02-28) ↗ |
| FY2015 | Dec 31, 2015 | 23.0% | – | Form 10-K (filed 2018-02-22) ↗ |
Breakdown
What makes up top 3 U.S. Pharmaceutical Wholesalers
Cite this data
StockData. (2026). Pfizer Top 3 U.S. Pharmaceutical Wholesalers (%), annual FY2015–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/conc-top3-ar
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.